Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.70 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.70 |
| ▸ | MAPT | P10636 | 3/20 | 0.70 |
| ▸ | LMNA | P02545 | 2/20 | 0.70 |
| ▸ | TSHR | P16473 | 2/20 | 0.70 |
| ▸ | BLM | P54132 | 2/20 | 0.70 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.70 |
| ▸ | MEN1 | O00255 | 2/20 | 0.70 |
| ▸ | MPO | P05164 | 1/20 | 0.70 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.70 |
| ▸ | DNMT1 | P26358 | 3/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | HTR1A | P08908 | 2/20 | 0.50 |
| ▸ | HTR2A | P28223 | 2/20 | 0.50 |
| ▸ | HTR2C | P28335 | 2/20 | 0.50 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.50 |
| ▸ | HTR7 | P34969 | 2/20 | 0.50 |
| ▸ | HTR2B | P41595 | 2/20 | 0.50 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4606618 | 0.96 | KDM4E (0.61) | KMT2AKDM4EMAPTLMNATSHR | |
| SCHEMBL4606621 | 0.96 | KDM4E (0.61) | KMT2AKDM4EMAPTLMNATSHR | |
| Cysteine SCHEMBL19971581 | 0.94 | KDM4E (0.61) | KMT2AKDM4EMAPTLMNATSHR | |
| Tryptophan SCHEMBL28531880 | 0.87 | KMT2A (0.86) | KMT2AKDM4EMAPTLMNATSHR | |
| Dl-Tryptophan SCHEMBL28267454 | 0.85 | KMT2A (0.97) | KMT2AKDM4EMAPTLMNATSHR | |
| Tryptophan SCHEMBL11064226 | 0.85 | KMT2A (0.97) | KMT2AKDM4EMAPTLMNATSHR | |
| Tryptophan SCHEMBL1839783 | 0.84 | KMT2A (0.80) | KMT2AKDM4EMAPTLMNATSHR | |
| Dl-Tryptophan SCHEMBL1839782 | 0.84 | KMT2A (0.80) | KMT2AKDM4EMAPTLMNATSHR | |
| Tryptophan SCHEMBL23141133 | 0.83 | KMT2A (1.00) | KMT2AKDM4EMAPTLMNATSHR | |
| Dl-Tryptophan SCHEMBL7327 | 0.83 | KMT2A (1.00) | KMT2AKDM4EMAPTLMNATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 181 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4644559-A1 | METHOD FOR ENZYME-ASSISTED PLASMA CHEMICAL REACTION | Leibniz-Institut für Plasmaforschung und Technologie e.V. (DE) | 2025-11-05 | — | — | EP | claimed |
| US-20240310288-A1 | TETRAZOLIUM-BASED COLORIMETRIC ASSAY | UNIVERSITY OF SOUTH CAROLINA | 2024-09-19 | — | — | US | claimed |
| US-11001812-B2 | Trichothecene-transforming alcohol dehydrogenase, method for transforming trichothecenes and trichothecene-transforming additive | ERBER AKTIENGESELLSCHAFT (AT) | 2021-05-11 | — | — | US | claimed |
| US-10745589-B2 | Chemical mechanical polishing (CMP) of cobalt-containing substrate | VERSUM MATERIALS US, LLC (US) | 2020-08-18 | — | — | US | claimed |
| US-20190172720-A1 | Chemical Mechanical Polishing (CMP) of Cobalt-Containing Substrate | VERSUM MATERIALS US, LLC (US) | 2019-06-06 | — | — | US | claimed |
| EP-3257910-B1 | CHEMICAL MECHANICAL POLISHING (CMP) COMPOSITION, METHOD AND SYSTEM FOR COBALT-CONTAINING SUBSTRATE | VERSUM MAT US LLC (US) | 2019-03-27 | — | — | EP | claimed |
| US-20170362466-A1 | Chemical Mechanical Polishing (CMP) of Cobalt-Containing substrate | VERSUM MATERIALS US, LLC (US) | 2017-12-21 | — | — | US | claimed |
| EP-3257910-A1 | CHEMICAL MECHANICAL POLISHING (CMP) COMPOSITION, METHOD AND SYSTEM FOR COBALT-CONTAINING SUBSTRATE | Versum Materials US, LLC (US) | 2017-12-20 | — | — | EP | claimed |
| US-20160027657-A1 | Chemical Mechanical Polishing (CMP) of Colbalt-Containing Substrate | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2016-01-28 | — | — | US | claimed |
| EP-2977418-A1 | CHEMICAL MECHANICAL POLISHING (CMP) OF COBALT-CONTAINING SUBSTRATE | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2016-01-27 | — | — | EP | claimed |
| US-20030064435-A1 | Compositions and methods for protein secretion | WEINER JOEL HIRSCH (CA) | 2003-04-03 | — | — | US | claimed |
| US-6335178-B1 | RECOMBINANT PRODUCTION OF SOLUBLE PROTEINS BY LINKING NUCLEOTIDE SEQUENCE OF INTEREST TO SEQUENCE ENCODING TWIN-ARGININE SIGNAL AMINO ACID SEQUENCE, THEN TRANSFORMING HOST CELL AND ALLOWING GENE EXPRESSION | UNIVERSITY OF ALBERTA (CA) | 2002-01-01 | — | — | US | claimed |
| EP-1068339-A1 | COMPOSITIONS AND METHODS FOR PROTEIN SECRETION | The Governors of the University of Alberta (CA) | 2001-01-17 | — | — | EP | claimed |
| WO-1999051753-A1 | COMPOSITIONS AND METHODS FOR PROTEIN SECRETION | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 1999-10-14 | — | — | WO | claimed |
| EP-4743437-A1 | DIESTER LIPIDS, LIPID NANOPARTICLE CONTAINING DIESTER LIPIDS, AND FORMULATIONS THEREOF | Providence Therapeutics Holdings Inc. (CA) | 2026-05-20 | — | — | EP | disclosed |
| EP-4731258-A1 | LIPID NANOPARTICLES CONTAINING DISULFIDE LIPIDS AND FORMULATIONS THEREOF | Providence Therapeutics Holdings Inc. (CA) | 2026-04-29 | — | — | EP | disclosed |
| EP-4022047-B1 | IMPROVED POLYPEPTIDES CAPABLE OF CONVERTING SUBSTRATE 3-KETO- DEOXYNIVALENOL INTO 3-EPI- DEOXYNIVALENOL | DSM Austria GmbH (AT) | 2026-04-22 | — | — | EP | disclosed |
| EP-0960192-A1 | SYNTHETIC POLYNUCLEOTIDES | THE UNIVERSITY OF SYDNEY (AU) | 1999-12-01 | — | — | EP | disclosed |
| WO-1999051753-A1 | COMPOSITIONS AND METHODS FOR PROTEIN SECRETION | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 1999-10-14 | — | — | WO | disclosed |
| WO-1998006830-A1 | SYNTHETIC POLYNUCLEOTIDES | THE UNIVERSITY OF SYDNEY (AU) | 1998-02-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11001812-B2 | Trichothecene-transforming alcohol dehydrogenase, method for transforming trichothecenes and trichothecene-transforming additive | ADH5, IDH3A, ADH4 | KMT2A 933/4885KDM4E 2762/4885MAPT 2999/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.